China Medical Technologies 6-K 2009
SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF THE
SECURITIES EXCHANGE ACT OF 1934
For the month of October 2009
Commission File Number: 000-51440
CHINA MEDICAL TECHNOLOGIES, INC.
(Translation of registrants name into English)
No. 24 Yong Chang North Road
Beijing Economic-Technological Development Area
Peoples Republic of China
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F X Form 40-F
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes No X
If Yes is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- N/A
TABLE OF CONTENTS
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Date: October 29, 2009
China Medical Technologies to Hold its Annual General Meeting on November 16, 2009
Beijing, October 28, 2009 China Medical Technologies, Inc. (the Company) (Nasdaq: CMED), a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced that the Company will hold its annual general meeting of shareholders at the Companys office at 24 Yong Chang North Road, Beijing Economic-Technological Development Area, Beijing 100176, the Peoples Republic of China on November 16, 2009 at 9:00 a.m., local time. Holders of record of ordinary shares of the Company at the close of business on October 2, 2009 are entitled to vote at the annual general meeting or any adjournment thereof in person or by proxy. Holders of the Companys American Depositary Shares (ADSs) who wish to exercise their voting rights for the underlying ordinary shares should follow the instructions that they receive from the depositary of the Companys ADS program, Citibank, N.A.
The notice of the annual general meeting, form of proxy card and the proxy statement that sets forth the proposal to be submitted for shareholders approval at the meeting are available on the Companys Investor Relations website at http://ir.chinameditech.com. The Company has filed its annual report, including its audited consolidated financial statements for the fiscal year ended March 31, 2009, on Form 20-F with the U.S. Securities and Exchange Commission (the SEC). The Companys annual report on Form 20-F can be accessed on the above-mentioned website of the Company, as well as on the SECs website at http://www.sec.gov. Shareholders and ADS holders can request a hard copy of the Companys annual report, free of charge, by email to IR@chinameditech.com.
About China Medical Technologies, Inc.
China Medical Technologies is a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic (IVD) products using Enhanced Chemiluminescence (ECLIA) technology, Fluorescent in situ Hybridization (FISH) technology and Surface Plasmon Resonance (SPR) technology to detect and monitor various diseases and disorders. For more information, please visit http://www.chinameditech.com.